David Orenstein | Picower Institute for Learning and Memory
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
MIT researchers uncover the structural properties and dynamics of deep classifiers, offering novel explanations for optimization, generalization, and approximation in deep networks.
David Orenstein | Picower Institute for Learning and Memory
First detailed mapping and modeling of thalamus inputs onto visual cortex neurons show brain leverages “wisdom of the crowd” to process sensory information.